Consultants Consulting Leveraging 
The Motley Fool
JANUARY 28, 2024
The company's secret weapon is its consulting business. Consulting is a core driver of our value proposition for clients," said IBM CEO Arvind Krishna in the fourth-quarter earnings call. Software drove just one-third of this business, with consulting signings driving the remaining two-thirds. This makes sense.
Private Equity Insights
AUGUST 31, 2023
In the aftermath of a rejected offer for EY’s consulting business, US private equity firm TPG has signed a definitive agreement to acquire a majority stake in Crowe’s healthcare consulting unit. read more The post After failed $100bn EY offer, TPG buys Crowe’s healthcare consulting unit appeared first on Private Equity Insights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Motley Fool
JULY 24, 2024
We had strong performance in software and infrastructure above our model as investment in innovation is yielding organic growth, while consulting remained below model. As we stated last quarter, factors such as interest rates and inflation impacted timing of decision making and discretionary spend in consulting.
The Motley Fool
JUNE 8, 2024
If you've had more than 25 years in the workplace, you've probably picked up skills that you can train others on or provide expertise as a consultant. For example, you could become a speaker, writer, author, consultant, and trainer by leveraging a single skill. Find out if your skills are in demand and how you can monetize them.
Private Equity Insights
SEPTEMBER 13, 2023
As part of that partnership, the two companies will collectively invest up to $2.5bn over the next five years, leveraging Mubadala’s long-term and strategic partnership with Apollo Global Management. Mubadala will hold 80% ownership of the Abu Dhabi Global Market-based joint venture entity, with the remaining 20% held by Alpha Dhabi.
The Motley Fool
OCTOBER 7, 2024
trillion to worldwide GDP, a 26% increase, according to a report by PwC, a leading global consulting firm. Recursion's revolutionary approach Recursion Pharmaceuticals (NASDAQ: RXRX) is pioneering a unique approach to drug discovery by leveraging AI and machine learning. By 2030, AI could add $15.7
The Motley Fool
SEPTEMBER 9, 2024
AI-consulting services A McKinsey survey found that 65% of organizations are using AI regularly, nearly double the rate reported in its survey just 10 months earlier. Consider asking happy customers if you can put up a sign advertising your business next to their display for the first week or leave them with business cards to pass out.
Expert insights. Personalized for you.
278 
Let's personalize your content